Spravato® is now available at New York Medical Behavioral Health.
Please speak to the doctor about treatment options.
![SPRAVATO-logo SPRAVATO LOGO](https://tmsforu.com/wp-content/uploads/2023/04/SPRAVATO-logo-300x117.jpg)
For adults:
If you struggle with treatment-resistant depression, there’s a different choice to turn to.
SPRAVATO® is a prescription nasal spray that can be used in combination with your oral antidepressant regimen to treat:
- Adults with treatment-resistant depression (TRD)
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not know if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
![SPRAVATO-womanorange](https://tmsforu.com/wp-content/uploads/2023/04/SPRAVATO-womanorange.jpg)
Today’s most commonly used oral antidepressants are thought to treat depression by increasing levels of neurotransmitters (serotonin, norepinephrine and dopamine) in areas of the brain that affect mood.
SPRAVATO® targets the N-methyl-D-aspartate (NMDA) receptor and is believed to work differently than currently available oral antidepressants.